Skip to main content
  • Bookmarks
  • Register
  • Login

NIH OIR/OTT Logo

Main Menu

  • Partnerships

    Partnerships

    These links provide access to the information that is commonly needed for companies or organizations interested in partnering with NIH. The information here covers the process from researching available technologies through fees associated.

    • Overview
    • Opportunities
    • Featured Technologies
    • Collaboration / CRADAs
    • Licensing Process
    • Forms / Model Agreements
    • Startups
    • Non-Profits
    • License Materials
    • Licensing FAQs
    • Business Opportunities
    • Product Showcase
    • Product Pipeline
    • Federal Register Notices

    The NIH cannot commercialize its discoveries even with its considerable size and resources — it relies instead upon partners. Typically, a royalty-bearing exclusive license agreement with the right to sublicense is given to a company from NIH to use patents, materials, or other assets to bring a therapeutic or vaccine product concept to market.

  • Royalties

    Royalties

    Information for inventors and licensees on the administration of royalties.

    • Information for NIH Inventors
    • Information for Licensees
    • License Notices / Reports
    • Royalty Coordinators
    • NIH Payment Center
    • CDC Payment Center

    Each year, hundreds of new inventions are made at NIH and CDC laboratories. Nine NIH Institutes or Centers (ICs) transfer NIH and CDC inventions through licenses to the private sector for further research and development and eventual commercialization.

  • Reports

    Reports

    These links provide access to reports tracking the success of NIH licensed products.

    • Annual Reports
    • Tech Transfer Statistics
    • Tech Transfer Metrics
    • Commercial Outcomes
    • HHS License-Based Vaccines & Therapeutics
    • Public Health & Economic Impact Study
    • Stories of Discovery
    • Chen Lecture Videos
    • NIH Patents and Active Patent Commercialization Licenses
    • Media Room
    • Tech Transfer Newsletters
    • NIH Patents and Patent Applications

    The NIH, CDC and FDA Intramural Research Programs are exceptionally innovative as exemplified by the many products currently on the market that benefit the public every day. Reports are generated from the commonly tracked metrics related to these products.

  • Resources

    Resources

    These links provide resources to those interested in the technology transfer activities at NIH.

    • Forms and Model Agreements
    • License Notices / Reports
    • Video Library
    • Inventor Resources
    • Presentations & Articles
    • FAQs
    • RSS Feeds
    • Inventor Showcase

    Past videos, lectures, presentations, and articles related to technology transfer at NIH are kept and made available to the public. These topics range from general technology transfer information to processes specific to NIH.

  • Policy & Regulations

    Policies & Regulations

    These links provide access to the policies and regulations surrounding partnering or collaborating with NIH.

    • Freedom of Information Act (FOIA)
    • PHS Technology Transfer Policy
    • Policies & Reports
    • Useful Links

    If a company would like to acquire rights to use or commercialize either an unpatented material, or a patented or patent-pending invention, a license is required. There are numerous policies and regulations surrounding the transfer or a technology from the NIH to a company or organization.

  • About

    About Us

    These links provide information about the Office of Technology Transfer.

    • Contact Us
    • Staff Directory
    • Management
    • FAQs
    • HHS Tech Transfer Offices & Contacts
    • Careers in Tech Transfer
    • Location & Directions
    • Feedback

    The NIH Office of Technology Transfer (OTT) plays a strategic role by supporting the patenting and licensing efforts of our NIH ICs. OTT protects, monitors, markets and manages the wide range of NIH discoveries, inventions, and other intellectual property as mandated by the Federal Technology Transfer Act and related legislation.

Breadcrumb

  1. Home
  2. Taxonomy
  3. Term
  4. NCI

Biomarkers Of Histone Deacetylase Inhibition

  • Read more about Biomarkers Of Histone Deacetylase Inhibition
US Application 60/735,714
Filed on 2005-11-12

Method of Screening For Hepatocellular Carcinoma

  • Read more about Method of Screening For Hepatocellular Carcinoma
US Application 60/732,332
Filed on 2005-11-01

Polyvalent Tether Nanoprobes: Single Molecule Detection Devices

  • Read more about Polyvalent Tether Nanoprobes: Single Molecule Detection Devices
US Application 60/749,858
Filed on 2005-12-12

The Medusa Sequencer: Nucleic Acid Sequencing Using A Single Molecule Device

  • Read more about The Medusa Sequencer: Nucleic Acid Sequencing Using A Single Molecule Device
US Application 60/749,729
Filed on 2005-12-12

Expansion of Natural Killer and CD8 T-cells With IL-15R/ligand Activator Complexes

  • Read more about Expansion of Natural Killer and CD8 T-cells With IL-15R/ligand Activator Complexes
US Application 60/750,639
Filed on 2005-12-14

Triapine-induced Tumor Cell Radiosensitization

  • Read more about Triapine-induced Tumor Cell Radiosensitization
US Application 60/718,172
Filed on 2005-09-16

Polysaccharide-derived Nitric Oxide-releasing Carbon-bound Diazeniumdiolates

  • Read more about Polysaccharide-derived Nitric Oxide-releasing Carbon-bound Diazeniumdiolates
US Application 60/731,946
Filed on 2005-10-31

Cyclic Phosphopeptide Inhibitors Of Protein 2c Delta, WIP1

  • Read more about Cyclic Phosphopeptide Inhibitors Of Protein 2c Delta, WIP1
US Application 60/850,218
Filed on 2006-10-06

Modification of Recombinant Ant-tumor RNase (rapLR1) For Optimal Use In The Large-scale Manufacture Of Stable And Potent RapLR1-antibody Conjugatyes

  • Read more about Modification of Recombinant Ant-tumor RNase (rapLR1) For Optimal Use In The Large-scale Manufacture Of Stable And Potent RapLR1-antibody Conjugatyes
US Application 60/722,295
Filed on 2005-09-30

Immunogenic Peptides and Methods of Use For Treating And Preventing Cancer

  • Read more about Immunogenic Peptides and Methods of Use For Treating And Preventing Cancer
US Application 60/733,319
Filed on 2005-11-03

Pagination

  • First page « First
  • Previous page ‹‹
  • …
  • Page 151
  • Page 152
  • Page 153
  • Page 154
  • Page 155
  • Page 156
  • Page 157
  • Page 158
  • Page 159
  • …
  • Next page ››
  • Last page Last »
Subscribe to NCI
NIH White Technology Transfer Logo

Return to Top

  • About
  • Privacy Notice
  • Accessibility
  • Web Policies & Notices
  • Open Data
  •  
  • For NIH Staff Only
  • HHS
  • NIH
  • HHS Vulnerability Disclosure
  • Connect
  • Twitter
  • LinkedIn
  • Contact
  • Feedback

Office of Technology Transfer, Office of Intramural Research, National Institutes of Health